Clinical Trial Update: SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating SBRT-LDRT with cadonilimab for advanced gastric, colorectal, and ovarian cancers with peritoneal metastases is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Peritoneal Metastasis

Drugs mentioned

• Cadonilimab (AK104) (Cadonilimab)

Snippet

Sponsor: Zhang Tao | Conditions: Advanced Gastric Cancer, Advanced Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING